Enbrel Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)
Conditions:   Ankylosing Spondylitis;   Axial Spondyloarthritis Interventions:   Biological: Adalimumab and its biosimilars;   Biological: Biological: Etanercept and its biosimilars;   Biological: Golimumab;   Biological: Infliximab biosimilar Sponsors:   Hanyang University Seoul Hospital;   Linical Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2021 Category: Research Source Type: clinical trials